Pzena Investment Management LLC Acquires 247,744 Shares of Humana Inc. $HUM

Pzena Investment Management LLC boosted its holdings in Humana Inc. (NYSE:HUM) by 6.5% during the second quarter, Holdings Channel reports. The institutional investor owned 4,076,667 shares of the insurance provider’s stock after buying an additional 247,744 shares during the period. Humana makes up 3.3% of Pzena Investment Management LLC’s portfolio, making the stock its 10th biggest holding. Pzena Investment Management LLC’s holdings in Humana were worth $996,664,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also recently added to or reduced their stakes in the company. Cary Street Partners Investment Advisory LLC boosted its stake in Humana by 63.9% in the 1st quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider’s stock worth $31,000 after buying an additional 46 shares during the last quarter. Garde Capital Inc. acquired a new stake in Humana in the 1st quarter worth about $36,000. Zions Bancorporation National Association UT acquired a new stake in Humana in the 1st quarter worth about $37,000. Ransom Advisory Ltd acquired a new stake in Humana in the 1st quarter worth about $66,000. Finally, Rakuten Securities Inc. boosted its stake in Humana by 50.0% in the 1st quarter. Rakuten Securities Inc. now owns 300 shares of the insurance provider’s stock worth $79,000 after buying an additional 100 shares during the last quarter. 92.38% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

HUM has been the topic of a number of research analyst reports. Wall Street Zen lowered Humana from a “buy” rating to a “hold” rating in a research note on Saturday, August 2nd. Guggenheim reaffirmed a “buy” rating on shares of Humana in a research note on Friday, October 3rd. Mizuho lifted their price objective on Humana from $300.00 to $345.00 and gave the company an “outperform” rating in a research note on Thursday. Sanford C. Bernstein lifted their price objective on Humana from $269.00 to $341.00 and gave the company an “outperform” rating in a research note on Friday, September 5th. Finally, Piper Sandler reduced their price objective on Humana from $288.00 to $272.00 and set a “neutral” rating on the stock in a research note on Thursday, July 31st. Eight equities research analysts have rated the stock with a Buy rating, ten have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $298.83.

Humana Stock Performance

Shares of NYSE:HUM opened at $280.24 on Monday. The company has a market cap of $33.71 billion, a P/E ratio of 21.51, a PEG ratio of 1.64 and a beta of 0.42. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.95 and a current ratio of 1.95. Humana Inc. has a one year low of $206.87 and a one year high of $315.35. The business’s 50-day simple moving average is $279.45 and its 200 day simple moving average is $258.04.

Humana (NYSE:HUM) last announced its earnings results on Wednesday, July 30th. The insurance provider reported $6.27 EPS for the quarter, missing the consensus estimate of $6.32 by ($0.05). The company had revenue of $32.39 billion for the quarter, compared to analysts’ expectations of $31.85 billion. Humana had a net margin of 1.28% and a return on equity of 13.67%. The business’s quarterly revenue was up 9.6% compared to the same quarter last year. During the same quarter in the previous year, the business posted $6.96 earnings per share. Humana has set its FY 2025 guidance at 17.000- EPS. On average, sell-side analysts forecast that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be issued a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a dividend yield of 1.3%. The ex-dividend date is Friday, September 26th. Humana’s dividend payout ratio (DPR) is presently 27.17%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.